This is the authors' abstract. We don't add key points for this paper.
Controlled hypoalbuminemia due to high albumin leakage (Alb-L) improves mortality in dialysis patients with mild weight loss and/or inflammation. However, no study has investigated whether it reduces mortality in old-old patients who tend to have progressively worsening hypoalbuminemia, weight loss, and inflammation over time. To address this question, this study retrospectively analyzed 227 dialysis patients aged ≥75 years who were classified into a high Alb-L group (≥3 g/session, n = 93) and a low Alb-L group (<3 g/session, n = 134). Propensity score matching was performed to compare 3-year all-cause mortality, yielding 93 matched patients in each group. In our facilities, hypoalbuminemia due to high Alb-L was acceptable down to serum Alb (S-Alb) of 3.0 g/dL in patients without overt weight loss and/or inflammation. Survival was assessed using Kaplan–Meier survival curves with patients censored when their Alb-L category changed during annual follow-up assessments. Mortality was significantly lower in the high Alb-L group than in the low Alb-L group (P = 0.007, log-rank test). Adjusted Cox proportional hazards regression analysis showed that mortality remained significantly lower in the high Alb-L group (adjusted hazard ratio [HR] 0.397, 95% confidence interval 0.184-0.859, P = 0.019). In a sensitivity analysis using the overlap weighting method in all 227 patients without censoring for changes in Alb-L category, the HR for high Alb-L remained below 1.0, but was not statistically significant relative to low Alb-L. In exploratory hypothesis-generating stratified subgroup analyses, body mass index (BMI) ≥20 kg/m2, high-sensitivity C-reactive protein (hs-CRP) level ≥0.3 mg/dL, and a group with BMI <22 kg/m2 and/or hs-CRP level ≥0.3 mg/dL were associated with lower mortality rates in high Alb-L than in low Alb-L, while no associations were observed for BMI <20 kg/m2, hs-CRP level <0.3 mg/dL, and a group with BMI ≥22 kg/m2 and hs-CRP <0.3 mg/dL. Although low Alb-L was associated with reduced S-Alb and BMI, and elevated serum creatinine (S-Cr) after 3 years, high Alb-L were associated with increased BMI, decreased S-Cr, and the prevention of reduced S-Alb level. Furthermore, in patients without inflammation, either high or low Alb-L was associated with elevated hs-CRP level after 3 years. In contrast, controlled hypoalbuminemia due to high Alb-L was associated with decreased hs-CRP level in patients with mild inflammation, but low Alb-L was not. Controlled hypoalbuminemia due to high Alb-L was associated with lower mortality relative to low Alb-L in exploratory analyses of patients aged ≥75 years with mild weight loss and/or inflammation.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Okada et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: